|
|
| | HIV-2 Peptide Basic information |
| Product Name: | HIV-2 Peptide | | Synonyms: | HIV-2 Peptide;L-Threonine, L-lysyl-L-α-aspartyl-L-glutaminyl-L-alanyl-L-glutaminyl-L-leucyl-L-asparaginyl-L-seryl-L-tryptophylglycyl-L-cysteinyl-L-alanyl-L-phenylalanyl-L-arginyl-L-glutaminyl-L-valyl-L-cysteinyl-L-histidyl-, cyclic (11→17)-disulfide (9CI);L-Threonine, L-lysyl-L-α-aspartyl-L-glutaminyl-L-alanyl-L-glutaminyl-L-leucyl-L-asparaginyl-L-seryl-L-tryptophylglycyl-L-cysteinyl-L-alanyl-L-phenylalanyl-L-arginyl-L-glutaminyl-L-valyl-L-cysteinyl-L-histidyl-, cyclic (11→17)-disulfide;H-KDQAQLNSWGCAFRQVCHT-OH | | CAS: | 172486-63-4 | | MF: | C93H140N30O28S2 | | MW: | 2190.43 | | EINECS: | | | Product Categories: | | | Mol File: | 172486-63-4.mol |  |
| | HIV-2 Peptide Chemical Properties |
| density | 1.56±0.1 g/cm3(Predicted) |
| | HIV-2 Peptide Usage And Synthesis |
| Uses | HIV-2 Peptide is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development[1]. | | References | [1] Birnbaum S, et al. Peptide screening. Current Opinion in Biotechnology, 1992, 3(1): 49-54. |
| | HIV-2 Peptide Preparation Products And Raw materials |
|